| Code | 2402B | ||||||||||
| MA number | 21/0041/70-CS | ||||||||||
| Product Form: | tbl flm 250x200 mg (obal PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | container PE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 20.03.1970 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Ospolot_08.2023.pdf
|
| SPC: |
SPC_Ospolot_08.2023.pdf
|
| Safety feature | Yes |
| Data update: | 04.10.2018 |
